Companies Face Costly System Overhauls With New FDA Regulations
Mark E. Kolb
Advertisement
Mark E. Kolb is CEO of Taratec Development, a consulting firm that provides e-technology and regulatory solutions for the life sciences industry.
Articles by Mark E. Kolb
Advertisement
Latest Updated Articles
- The Next Y2K
Published: May 1st 2001 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Submit Oral GLP-1 for FDA Priority Review Program: Report
2
GCC Emerges as a New Strategic Anchor for Global Venture Capital
3
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
4
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
5
